Adams Diversified Equity Fund’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-4,488
| Closed | -$380K | – | 234 |
|
2018
Q4 | $380K | Buy |
4,488
+1,282
| +40% | +$109K | 0.02% | 198 |
|
2018
Q3 | $549K | Sell |
3,206
-2,405
| -43% | -$412K | 0.03% | 189 |
|
2018
Q2 | $725K | Sell |
5,611
-480
| -8% | -$62K | 0.04% | 152 |
|
2018
Q1 | $628K | Hold |
6,091
| – | – | 0.03% | 172 |
|
2017
Q4 | $520K | Sell |
6,091
-1,764
| -22% | -$151K | 0.03% | 196 |
|
2017
Q3 | $667K | Buy |
+7,855
| New | +$667K | 0.04% | 201 |
|
2016
Q4 | – | Sell |
-4,168
| Closed | -$310K | – | 234 |
|
2016
Q3 | $310K | Hold |
4,168
| – | – | 0.02% | 178 |
|
2016
Q2 | $310K | Buy |
+4,168
| New | +$310K | 0.02% | 178 |
|